328
Participants
Start Date
January 31, 2009
Primary Completion Date
March 31, 2010
BI 1744 CL 2 µg
2 puffs of 1 µg/actuation delivered by the Respimat® inhaler
BI 1744 CL 5 µg
2 puffs of 2.5 µg/actuation delivered by the Respimat® inhaler
BI 1744 CL 10 µg
2 puffs of 5 µg/actuation delivered by Respimat®
Placebo
2 puffs delivered by the Respimat® inhaler
1222.22.048 Boehringer Ingelheim Investigational Site, Asahikawa, Hokkaido
1222.22.044 Boehringer Ingelheim Investigational Site, Bunkyo-ku, Tokyo
1222.22.008 Boehringer Ingelheim Investigational Site, Chiba, Chiba
1222.22.002 Boehringer Ingelheim Investigational Site, Fukuoka, Fukuoka
1222.22.041 Boehringer Ingelheim Investigational Site, Fukuoka, Fukuoka
1222.22.027 Boehringer Ingelheim Investigational Site, Himeji, Hyogo
1222.22.028 Boehringer Ingelheim Investigational Site, Himeji, Hyogo
1222.22.018 Boehringer Ingelheim Investigational Site, Hiroshima, Hiroshima
1222.22.021 Boehringer Ingelheim Investigational Site, Hitachi, Ibaraki
1222.22.010 Boehringer Ingelheim Investigational Site, Inashiki-gun, Ibaraki
1222.22.012 Boehringer Ingelheim Investigational Site, Itabashi-ku, Tokyo
1222.22.009 Boehringer Ingelheim Investigational Site, Kamogawa, Chiba
1222.22.023 Boehringer Ingelheim Investigational Site, Kawasaki, Kanagawa
1222.22.025 Boehringer Ingelheim Investigational Site, Kawasaki, Kanagawa
1222.22.017 Boehringer Ingelheim Investigational Site, Kishiwada, Osaka
1222.22.004 Boehringer Ingelheim Investigational Site, Kitakyusyu, Fukuoka
1222.22.020 Boehringer Ingelheim Investigational Site, Koga, Fukuoka
1222.22.014 Boehringer Ingelheim Investigational Site, Komaki, Aichi
1222.22.032 Boehringer Ingelheim Investigational Site, Kumamoto, Kumamoto
1222.22.005 Boehringer Ingelheim Investigational Site, Kurume, Fukuoka
1222.22.029 Boehringer Ingelheim Investigational Site, Kurume, Fukuoka
1222.22.033 Boehringer Ingelheim Investigational Site, Kyoto, Kyoto
1222.22.050 Boehringer Ingelheim Investigational Site, Kyoto, Kyoto
1222.22.022 Boehringer Ingelheim Investigational Site, Matsumoto, Nagano
1222.22.015 Boehringer Ingelheim Investigational Site, Nagoya, Aichi
1222.22.043 Boehringer Ingelheim Investigational Site, Nagoya, Aichi
1222.22.001 Boehringer Ingelheim Investigational Site, Naka-gun, Ibaraki
1222.22.007 Boehringer Ingelheim Investigational Site, Niigata, Niigata
1222.22.040 Boehringer Ingelheim Investigational Site, Obihiro, Hokkaido
1222.22.042 Boehringer Ingelheim Investigational Site, Okinawa, Okinawa
1222.22.034 Boehringer Ingelheim Investigational Site, Osaka, Osaka
1222.22.038 Boehringer Ingelheim Investigational Site, Osaka, Osaka
1222.22.049 Boehringer Ingelheim Investigational Site, Osaka, Osaka
1222.22.045 Boehringer Ingelheim Investigational Site, Osaka-sayama, Osaka
1222.22.019 Boehringer Ingelheim Investigational Site, Sakai, Oasaka
1222.22.006 Boehringer Ingelheim Investigational Site, Sapporo, Hokkaido
1222.22.051 Boehringer Ingelheim Investigational Site, Sashima-gun, Ibaraki
1222.22.031 Boehringer Ingelheim Investigational Site, Sendai, Miyagi
1222.22.013 Boehringer Ingelheim Investigational Site, Seto, Aichi
1222.22.024 Boehringer Ingelheim Investigational Site, Shibata-gun, Miyagi
1222.22.003 Boehringer Ingelheim Investigational Site, Takarazuka, Hyogo
1222.22.026 Boehringer Ingelheim Investigational Site, Tsukuba, Ibaraki
1222.22.030 Boehringer Ingelheim Investigational Site, Ube, Yamaguchi
1222.22.037 Boehringer Ingelheim Investigational Site, Uji, Kyoto
1222.22.047 Boehringer Ingelheim Investigational Site, Wakayama, Wakayama
1222.22.016 Boehringer Ingelheim Investigational Site, Yamagata, Yamagata
1222.22.036 Boehringer Ingelheim Investigational Site, Yao, Osaka
1222.22.011 Boehringer Ingelheim Investigational Site, Yokohama, Kanagawa
Lead Sponsor
Boehringer Ingelheim
INDUSTRY